CSIMarket



Exelixis Inc.  (EXEL)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare

Exelixis's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


Return On Equity (Jul 01 2022)
II. Quarter
(Apr 01 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Oct 01 2021)
III. Quarter
(Jul 02 2021)
II. Quarter
Y / Y Equity Change 17.04 % 20.02 % 17.64 % 14.06 % -
Y / Y Net Income Change 65.65 % 9506.62 % 1083.81 % - 43.81 %
Net Income (TTM) in Millions 741 677 525 218 94
Return On Equity (TTM) 32.88 % 31.29 % 25.38 % 10.95 % 4.89 %
Total Ranking # 461 # 520 # 723 # 1571 # 2188
Equity (TTM) in Millions 2,391 2,294 2,211 2,112 2,043
Seq. Equity Change 4.25 % 3.77 % 4.65 % 3.4 % 6.9 %
Seq. Net Income Change 3.5 % -54.23 % 267.42 % - 5902 %


Roe Comment
Exelixis Inc. returned in II. Quarter 32.88 % on shareholder's equity, that was lower than company average return on equity.

ROE improved compare to previous quarter, due to net income growth.

Within Healthcare sector 46 other companies have achieved higher return on equity. While Return on equity total ranking has impoved so far to 468, from total ranking in previous quarter at 522.

What is ROE?
Return On Equity Company Ranking
Within: No.
Industry # 3
Sector # 47
Overall # 466

Return On Equity Statistics
High Average Low
104.08 %
41.37 %
3.47 %
(Sep 30 2017)   (Apr 02 2021)


Annual Return On Equity (Dec 31 2021)
2021
(Jan 01 2021)
2020
(Jan 03 2020)
2019
(Dec 28 2018)
2018
(Dec 29 2017)
2017
Total Equity in Millions 2,211 1,879 1,686 1,287 285
Y / Y Equity Change 17.64 % 11.46 % 30.95 % 351.8 % 219.04 %
Net Income in Millions 525 112 321 690 154
Y / Y Net Income Change 369.86 % -65.18 % -53.48 % 347.44 % -
Return On Equity 23.76 % 5.95 % 19.04 % 53.6 % 54.12 %





Annual Roe Comment
In 2021 ROE improved to 23.76 % compare to previous year, due to net income growth.


Financial Statements
Exelixis's Equity $ 2,391 Millions EXEL's Balance sheet
Exelixis's Income $ 159 Millions Quarterly EXEL's Income Statement
EXEL's Income by Division See EXEL's Income by Division

More Return On Equity Ratios
Medical Laboratories Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
Roe Trends for overall market
EXEL's Roe Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for EXEL's Competitors
Return On Equity for Exelixis's Suppliers
Roe for EXEL's Customers

You may also want to know
EXEL's Roa EXEL's Inventory Turnover Ratio EXEL's Growth Rates EXEL's Dividend Statistics
EXEL's Profitability Ratios EXEL's Asset Turnover Ratio EXEL's Dividend Growth
EXEL's Roi EXEL's Valuation Ratios EXEL's Financial Strength Ratios EXEL's Dividend Payout Ratio



Companies with similar Return On Equity at Jul 01 2022, within Healthcare Sector ROE
Journey Medical Corporation  85.14 %
Selecta Biosciences Inc  85.07 %
Abbvie Inc.  84.29 %
Biomx Inc.  83.21 %
Vicarious Surgical Inc.  82.59 %
Avalo Therapeutics Inc.  81.00 %
Harpoon Therapeutics Inc.  80.40 %
Sensus Healthcare Inc.  74.85 %
Tenet Healthcare Corp  74.11 %
Vir Biotechnology Inc.  68.86 %
Oncotelic Therapeutics Inc.  68.05 %
Biofrontera Inc.  65.87 %
Eli Lilly And Company  64.62 %
Iteos Therapeutics Inc.  60.26 %
180 Life Sciences Corp.  59.53 %
Vyne Therapeutics Inc.  54.91 %
Siga Technologies Inc  48.79 %
Glucotrack Inc.  47.72 %
Reflect Scientific Inc  47.53 %
National Research Corporation  45.39 %
Zoetis Inc.  45.24 %
Prophase Labs Inc.  43.98 %
Merck and Co. Inc.  41.90 %
Enact Holdings Inc.  41.81 %
Innoviva Inc.  38.87 %
Cryo cell International Inc.  38.23 %
Chemed Corporation  37.40 %
Quidelortho Corp  36.94 %
Pfizer Inc  36.26 %
Hanger inc.  34.41 %



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ATAI's Profile

Stock Price

ATAI's Financials

Business Description

Fundamentals

Charts & Quotes

ATAI's News

Suppliers

ATAI's Competitors

Customers & Markets

Economic Indicators

ATAI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071